Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$135.99 USD
-1.77 (-1.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $135.92 -0.07 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NBIX 135.99 -1.77(-1.28%)
Will NBIX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NBIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NBIX
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
NBIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Neurocrine (NBIX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for NBIX
Promising Outlook for Neurocrine’s NBI-‘845 in MDD Market Based on Strong Phase 2 Results and Competitive Positioning
Buy Rating Affirmed for Neurocrine on Promising Phase 2 SAVITRI Study Results
Maintaining Hold on Neurocrine Amid Promising Yet Uncertain Clinical Developments
Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data
Neurocrine Biosciences upgraded at Wells Fargo on pipeline